Gainers
- Jasper Therapeutics, Inc. JSPR shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
- Waitr Holdings Inc WTRH gained 58.5% to close at $1.27 after Morgan Stanley reported a 10.3% passive stake in the company.
- Sono-Tek Corporation SOTK jumped 44.2% to close at $6.49. Sono-Tek reported second-quarter FY22 net sales growth of 17% year-on-year to $4.07 million. Sono-Tek sees double-digit sales increases for both the Q3 and Q4 of FY22 based on backlog strength. Sono-Tek sees the growth to generate strong annual sales for FY22.
- Catalyst Bancorp, Inc. CLST gained 35.6% to close at $13.56.
- Clarus Therapeutics Holdings, Inc. CRXT surged 29% to settle at $5.29 after Truist Securities initiated coverage on the stock with a Buy rating and a $10 price target.
- Orphazyme A/S ORPH gained 23.4% to close at $4.91. Orphazyme received Notice of Allowance for U.S. patent titled 'Arimoclomol For Treating Glucocerebrosidase Associated Disorders.'
- Puxin Limited NEW jumped 23% to close at $0.5580 after dipping 24% on Tuesday.
- Redwire Corporation RDW gained 22% to settle at $12.13. Redwire said it will provide critical navigation components for NASA's Lucy Mission to study Jupiter's Trojan Asteroids.
- Huadi International Group Co., Ltd. HUDI gained 19.6% to close at $5.99.
- Independence Contract Drilling, Inc. ICD rose 18.9% to settle at $4.27.
- Allogene Therapeutics, Inc. ALLO gained 18.7% to close at $15.94
- SMART Global Holdings, Inc. SGH climbed 18.1% to close at $51.72 after the company reported better-than-expected Q4 results and issued Q1 EPS guidance above estimates.
- Relay Therapeutics, Inc. RLAY gained 18% to close at $32.76, rebounding after the stock dipped Tuesday following Monday news of a $350 million common stock offering.
- Lightbridge Corporation LTBR surged 16.9% to close at $6.42.
- Sphere 3D Corp. ANY gained 15.6% to close at $8.13 after the company announced it entered into an agreement with Gryphon Digital Mining for approximately 230 MW of carbon neutral bitcoin mining hosting capacity to be managed by Core Scientific as hosting partner.
- NuCana plc NCNA rose 15.6% to settle at $2.81.
- Standard Lithium Ltd. SLI gained 15.3% to close at $9.70.
- Statera Biopharma, Inc. STAB climbed 15.2% to close at $3.11.
- TaskUs, Inc. TASK gained 15.1% to settle at $64.95.
- RLX Technology Inc. RLX shares gained 14.9% to close at $5.33 after declining around 5% on Tuesday.
- iPower Inc. IPW climbed 14.5% to close at $3.3550.
- Vimeo, Inc. VMEO gained 13.6% to close at $30.41 after the company posted monthly metrics for September 2021.
- Revance Therapeutics, Inc. RVNC rose 12.9% to close at $23.08 after the company announced it continues to anticipate FDA approval of DaxibotulinumtoxinA for Injection for the treatment of glabellar lines in 2021.
- Plug Power Inc. PLUG climbed 12.8% to close at $33.59 after the company announced two new strategic partnerships.
- Vistra Corp. VST shares climbed 11% to close at $19.81 after the company announced a $2 billion buyback.
- Paltalk, Inc. PALT climbed 10.7% to close at $8.72.
- Sentage Holdings Inc. SNTG gained 7% to close at $2.77 after climbing over 18% on Tuesday.
- JAKKS Pacific, Inc. JAKK gained 6.2% to close at $12.57.
- Grom Social Enterprises, Inc. GROM rose 5.9% to close at $4.30. Grom Social Enterprises recently announced its wholly-owned subsidiary, Top Draw Animation, has commenced production on approximately $1 million in new projects through its sprawling studio in Manila, the Philippines.
- SAP SE SAP rose 5.2% to close at $141.65 after the company announced preliminary Q3 financial results and raised its FY21 guidance.
- InspireMD, Inc. NSPR gained 5.1% to close at $4.12 after the company announced it received reimbursement approval for CGuard Embolic Prevent System from the French National Authority for Health.
Check out these big penny stock gainers and losers
Losers
- XORTX Therapeutics Inc. XRTX shares fell 34.1% to close at $3.14 on Wednesday.
- Regulus Therapeutics Inc. RGLS shares dipped 29.9% to close at $0.5326 on Wednesday after the company announced a strategic prioritization of its next-generation candidate, RGLS8429, for the treatment of ADPKD. The company's previous ADPKD candidate, RGLS4326, will no longer be advanced.
- NeuroOne Medical Technologies Corporation. NMTC dropped 29.4% to close at $2.91 after the company priced a 3.75 million share common stock offering at $3.20 per share.
- DatChat, Inc. DATS shares fell 26.7% to close at $11.00 amid a pullback following the stock's recent run.
- Neuronetics, Inc. STIM dipped 24.5% to close at $4.83 after the company cut Q3 and FY21 sales guidance below estimates. BTIG downgraded Neuronetics from Buy to Neutral.
- ESS Tech, Inc. GWH declined 19.9% to close at $19.07 after jumping 128% on Tuesday.
- Rezolute, Inc. RZLT dipped 14.2% to close at $6.53 after the company priced a roughly 6 million share common stock offering at $6.50 per share.
- NRx Pharmaceuticals, Inc. NRXP fell 13.6% to close at $9.44. NRX Pharmaceuticals shares jumped 61% on Tuesday after the company announced progress on the worldwide commercial scale development of ZYESAMI.
- Atara Biotherapeutics, Inc. ATRA dipped 12.9% to close at $15.66 after the company highlighted the presentation of new magnetization transfer ratio imaging data and two-year clinical data from open-label extension of ATA188 for progressive multiple sclerosis at ECTRIMS 2021.
- Sarepta Therapeutics, Inc. SRPT dropped 12.5% to close at $83.22 after the company announced a proposed $500 million public offering of common stock. The company also issued Q3 guidance.
- Adagio Therapeutics, Inc. ADGI fell 12.1% to settle at $30.74.
- GrowGeneration Corp. GRWG dropped 11.9% to close at $20.92 after the company announced a mutual termination of the HGS acquisition and issued Q3 and FY21 revenue guidance below estimates.
- Cytosorbents Corporation CTSO shares fell 11.5% to close at $6.13 after the company reported preliminary Q3 results and received full FDA Investigational Device Exemption approval to begin US STAR-D trial on apixaban and rivaroxaban removal by DrugSorb-ATR antithrombotic removal system during urgent cardiothoracic surgery.
- Evolent Health, Inc. EVH fell 11.5% to close at $29.32.
- Nutriband Inc. NTRB fell 11.2% to close at $8.61. Nutriband shares jumped 31% on Tuesday after the company announced it signed an exclusive manufacturing agreement for Diocheck visual COVID-19 antibody indicator patch.
- ZIVO Bioscience, Inc. ZIVO fell 9.8% to close at $4.04 after gaining over 18% on Tuesday.
- InvenTrust Properties Corp. IVT fell 9.5% to close at $23.52.
- Sun Country Airlines Holdings, Inc. SNCY fell 9.2% to close at $32.26 after reporting an 8 million offering by selling shareholders.
- CRISPR Therapeutics AG CRSP shares fell 5.7% to close at $96.77 after the company reported results from its Phase 1 CARBON trial of CTX110 in relapsed or refractory CD19+ B-cell malignancies.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From Yesterday
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in